{
      "ptx_code": "PTX107",
      "chem_name": "17alpha-Ethinylestradiol",
      "casrn": "57-63-6",
      "dtxsid": "DTXSID5020576",
      "smiles": "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3",
      "inchikey": "BFPYWIDHMRZLRN-SLHNCBLASA-N",
      "label": "PTX107 | 17alpha-Ethinylestradiol",
      "drugbank_id": "DB00977",
      "use_class": "Endogenous",
      "tox_class": "Genotoxicity; Immunotoxicity; Hepatotoxicity",
      "chem_name_user": "17alpha-Ethinylestradiol",
      "mw_g_mol": "296.41",
      "solubility_h2o_mol_liter": "3.94e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "9.44e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "5.41",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "10.00;13.71",
      "pka_base": "",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "3.67",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "3.89",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "0.07",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "average_mass": "296.41",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "143.5 \u00b0C",
      "source_melting_point": "Jean-Claude Bradley Open Melting Point Dataset",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "23.44",
      "baseline_dmagna": "22.13",
      "baseline_celegans": "48.98",
      "baseline_xlaevis": "32.62",
      "baseline_dmelanogaster": "188.28",
      "baseline_cells": "2.47e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "1.66e-06",
      "moa_drugbank": "Ethinylestradiol is a synthetic estrogenic compound.[L11944] Use of estrogens have a number of effects on the body including reduced bone density.[A191565] Combined oral contraceptives suppress ovulation by suppressing gonadotrophic hormone, thickening cervical mucus to prevent the travel of sperm, and preventing changes in the endometrium required for implantation of a fertilized egg.[A191568,L11944] Ethinylestradiol decreases luteinizing hormone, decreasing vascularity in the endometrium.[A191571] It also increases sex hormone binding globulin.[A191571]",
      "protein_binding": "Enthinylestradiol is 98.3-98.5% bound to albumin in serum[A191182] but also exhibits binding to sex hormone binding globulin.[A20240]",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 97,
                  "AOP_name": "5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline "
            },
            {
                  "AOP_id": 98,
                  "AOP_name": "5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            },
            {
                  "AOP_id": 148,
                  "AOP_name": "EGFR Activation Leading to Decreased Lung Function "
            },
            {
                  "AOP_id": 167,
                  "AOP_name": "Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse. "
            },
            {
                  "AOP_id": 187,
                  "AOP_name": "Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage "
            },
            {
                  "AOP_id": 195,
                  "AOP_name": "5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase "
            },
            {
                  "AOP_id": 200,
                  "AOP_name": "Estrogen receptor activation leading to breast cancer   "
            },
            {
                  "AOP_id": 203,
                  "AOP_name": "5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline "
            },
            {
                  "AOP_id": 204,
                  "AOP_name": "5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "Androgen receptor",
            "Bile acid receptor",
            "Cytochrome P450 2C18",
            "Cytochrome P450 2C19",
            "Cytochrome P450 2C9",
            "Cytochrome P450 2J2",
            "Cytochrome P450 3A5",
            "Estrogen receptor alpha",
            "Estrogen receptor beta",
            "Glucocorticoid receptor",
            "Nuclear receptor subfamily 1 group I member 2",
            "Nuclear receptor subfamily 1 group I member 3",
            "Progesterone receptor",
            "Sodium-dependent dopamine transporter",
            "Sodium-dependent noradrenaline transporter",
            "Sodium-dependent serotonin transporter",
            "Translocator protein"
      ]
}